Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA02000037 9,10 EpOME cPLA2i 1.0 BCD110605C30 0.021 pmol/ml medium
LMFA02000037 9,10 EpOME cPLA2i 1.0 BCD110605C29 0.024 pmol/ml medium
LMFA02000037 9,10 EpOME cPLA2i 1.0 BCD110605C28 0.02 pmol/ml medium
LMFA02000037 9,10 EpOME cPLA2i 20.0 BCD110605C64 0.032 pmol/ml medium
LMFA02000037 9,10 EpOME cPLA2i 20.0 BCD110605C66 0.037 pmol/ml medium
LMFA02000037 9,10 EpOME cPLA2i 20.0 BCD110605C65 0.033 pmol/ml medium
LMFA02000037 9,10 EpOME PLDi 1.0 BCD110605C16 0.032 pmol/ml medium
LMFA02000037 9,10 EpOME PLDi 1.0 BCD110605C18 0.027 pmol/ml medium
LMFA02000037 9,10 EpOME PLDi 1.0 BCD110605C17 0.025 pmol/ml medium
LMFA02000037 9,10 EpOME PLDi 20.0 BCD110605C54 0.034 pmol/ml medium
LMFA02000037 9,10 EpOME PLDi 20.0 BCD110605C52 0.035 pmol/ml medium
LMFA02000037 9,10 EpOME PLDi 20.0 BCD110605C53 0.033 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+cPLA2i 1.0 BCD110605C31 0.023 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+cPLA2i 1.0 BCD110605C33 0.02 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+cPLA2i 1.0 BCD110605C32 0.017 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+cPLA2i 20.0 BCD110605C68 0.024 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+cPLA2i 20.0 BCD110605C69 0.028 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+cPLA2i 20.0 BCD110605C67 0.02 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+PLDi 1.0 BCD110605C21 0.026 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+PLDi 1.0 BCD110605C20 0.021 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+PLDi 1.0 BCD110605C19 0.02 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+PLDi 20.0 BCD110605C57 0.037 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+PLDi 20.0 BCD110605C56 0.03 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+PLDi 20.0 BCD110605C55 0.036 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+cPLA2i 1.0 BCD110605C37 0.032 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+cPLA2i 1.0 BCD110605C39 0.025 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+cPLA2i 1.0 BCD110605C38 0.018 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+cPLA2i 20.0 BCD110605C74 0.014 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+cPLA2i 20.0 BCD110605C73 0.01 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+cPLA2i 20.0 BCD110605C75 0.014 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+PLDi 1.0 BCD110605C27 0.03 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+PLDi 1.0 BCD110605C25 0.023 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+PLDi 1.0 BCD110605C26 0.019 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+PLDi 20.0 BCD110605C62 0.017 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+PLDi 20.0 BCD110605C63 0.013 pmol/ml medium
LMFA02000037 9,10 EpOME KDO+ATP+PLDi 20.0 BCD110605C61 0.015 pmol/ml medium
LMFA02000037 9,10 EpOME KDO + ATP 1.0 BCD110605C14 0.023 pmol/ml medium
LMFA02000037 9,10 EpOME KDO + ATP 1.0 BCD110605C15 0.024 pmol/ml medium
LMFA02000037 9,10 EpOME KDO + ATP 1.0 BCD110605C13 0.017 pmol/ml medium
LMFA02000037 9,10 EpOME KDO + ATP 20.0 BCD110605C49 0.016 pmol/ml medium
LMFA02000037 9,10 EpOME KDO + ATP 20.0 BCD110605C51 0.016 pmol/ml medium
LMFA02000037 9,10 EpOME KDO + ATP 20.0 BCD110605C50 0.022 pmol/ml medium
LMFA02000037 9,10 EpOME KDO 1.0 BCD110605C09 0.025 pmol/ml medium
LMFA02000037 9,10 EpOME KDO 1.0 BCD110605C08 0.029 pmol/ml medium
LMFA02000037 9,10 EpOME KDO 1.0 BCD110605C07 0.025 pmol/ml medium
LMFA02000037 9,10 EpOME KDO 20.0 BCD110605C45 0.035 pmol/ml medium
LMFA02000037 9,10 EpOME KDO 20.0 BCD110605C44 0.039 pmol/ml medium
LMFA02000037 9,10 EpOME KDO 20.0 BCD110605C43 0.032 pmol/ml medium
LMFA02000037 9,10 EpOME C 0.0 BCD110605C02 0.034 pmol/ml medium
LMFA02000037 9,10 EpOME C 0.0 BCD110605C01 0.025 pmol/ml medium